Home Money Oxford Biomedica plc (OXBDF) Q4 2023 Earnings Call Transcript

Oxford Biomedica plc (OXBDF) Q4 2023 Earnings Call Transcript

0
Oxford Biomedica plc (OXBDF) Q4 2023 Earnings Call Transcript

[ad_1]

Oxford Biomedica plc (OTCPK:OXBDF) Q4 2023 Earnings Conference Call April 29, 2024 8:00 AM ET

Company Participants

Frank Mathias – Chief Executive Officer
Sébastien Ribault – Chief Commercial Officer
Stuart Paynter – Chief Financial Officer
Thierry Cournez – Chief Operating Officer

Conference Call Participants

Charles Weston – RBC
John Priestner – JPMorgan
Max Herman – Stifel
Julie Simmonds – Panmure Gordon
Paul Cuddon – Numis Securities
Myles Dixon – Peel Hunt

Frank Mathias

Good afternoon, everyone. And obviously, good morning to those on the other side of the ocean. Thank you so much for joining today’s Analyst Briefing of our 2023 Preliminary Results.

I am Frank Mathias, the COO of Oxford Biomedica. And it’s a pleasure to see so many familiar faces here in this room; so thank you for coming. To be here to speak to those on the webcast and those joining via the conference call lines today; with me I have our Chief Financial Officer, Stuart Paynter; our Chief Commercial Officer, Dr. Sébastien Ribault. And I’m also proud for the first time to have joining me, Thierry Cournez, our relatively new appointed Chief Operating Officer, who is also in charge of the UK operations. As I believe that you have all met Stuart and Sébastien before, I will Thierry introduce himself when he starts his section of the presentation shortly.

So looking at 2023, it’s obvious that 2023 was a year of transformation for Oxford Biomedica, as we began building a global pure place, cell and gene therapy CDMO. Throughout the year, we have met significant milestones and celebrated many successes which have provided me and the Board with confidence in our new strategy and it’s ability to deliver long-term sustainable growth. I will begin this presentation by highlighting these achievements and the progress we have made to transform the company before handing

[ad_2]

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here